NRXBF: Test Results Show Spinal Injury Recovery
NurExone (OTC-NRXBF) is a preclinical stage biotech company that is developing a breakthrough treatment for spinal cord injuries that has the...
186 Views
NRXBF: Raising Price Target on Trial Announcement
NurExone (OTC-NRXBF) is a preclinical stage biotech company that is developing a breakthrough treatment for spinal cord injuries that has the...
241 Views
NRXBF: Company Remains Disciplined Amid Progress
NurExone (OTC-NRXBF) is a preclinical stage biotech company that is developing a breakthrough treatment for spinal cord injuries that has the...
225 Views
NRXBF: Critical Year Starts with Company in Good Shape
NurExone (OTC-NRXBF) is a preclinical stage biotech company that is developing a breakthrough treatment for spinal cord injuries that has the...
419 Views
NRXBF: Tests Confirm Potential for Spinal Cord Injury Recovery
NurExone (OTC-NRXBF) is a preclinical stage biotech company that is developing a breakthrough treatment for spinal cord injuries that has the...
261 Views